Danaher Corporation $DHR Shares Purchased by Capital Advisors Inc. OK

Capital Advisors Inc. OK boosted its stake in Danaher Corporation (NYSE:DHR) by 6.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 230,926 shares of the conglomerate’s stock after buying an additional 13,796 shares during the quarter. Capital Advisors Inc. OK’s holdings in Danaher were worth $52,863,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new position in shares of Danaher during the third quarter valued at approximately $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher during the second quarter worth approximately $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher during the third quarter worth approximately $27,000. Finally, TruNorth Capital Management LLC acquired a new position in Danaher in the 3rd quarter valued at $28,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

Shares of DHR stock opened at $189.33 on Wednesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The company has a market capitalization of $133.99 billion, a PE ratio of 37.57, a price-to-earnings-growth ratio of 2.49 and a beta of 0.93. The firm’s 50-day moving average is $207.36 and its two-hundred day moving average is $214.61. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.14 EPS. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a $0.40 dividend. The ex-dividend date is Friday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s dividend payout ratio (DPR) is currently 31.75%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Leerink Partners lifted their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Robert W. Baird set a $251.00 price target on shares of Danaher in a research note on Thursday, January 29th. Argus set a $265.00 price objective on shares of Danaher in a research note on Wednesday, January 14th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Nineteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $253.55.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 11.20% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.